pyrazines has been researched along with Hypertrophy in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Alharbi, HO; Clerk, A; Cooper, STE; Cull, JJ; Fuller, SJ; Meijles, DN; Sugden, PH | 1 |
Cheng, M; Han, L; Li, M; She, T; Shi, C; Yu, L | 1 |
Ji, XX; Qian, W; Song, XL; Yu, XL; Zhu, JY | 1 |
Lü, D; Ma, CM; Qin, C; Wang, SM; Zhang, L; Zhang, LF; Zhang, W; Zhao, HP | 1 |
Gao, MH; Li, B; Ren, SR; Zhang, B; Zhang, L | 1 |
Doggrell, SA; Surman, AJ | 1 |
Haddow, A; Ross, WC; Timmis, GM | 1 |
7 other study(ies) available for pyrazines and Hypertrophy
Article | Year |
---|---|
The insulin receptor family and protein kinase B (Akt) are activated in the heart by alkaline pH and α1-adrenergic receptors.
Topics: Alkalies; Animals; Animals, Newborn; Female; Fibrosis; Humans; Hydrogen-Ion Concentration; Hypertrophy; Imidazoles; Insulin; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrazines; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Receptors, Adrenergic, alpha-1 | 2021 |
Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
Topics: Angiotensin II; Animals; Cell Enlargement; Cells, Cultured; Enzyme Activation; Gene Expression Regulation; Hypertrophy; Myocytes, Cardiac; NF-kappa B; Protein Biosynthesis; Protein Transport; Pyrazines; Rats; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |
Effects and mechanism of action of ligustrazine on isoprenaline-induced cardiomyocyte hypertrophy.
Topics: Animals; Calcium Channel Blockers; Calcium Signaling; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Hypertrophy; Isoproterenol; Myocytes, Cardiac; Pyrazines; Rats; Rats, Wistar; Reactive Oxygen Species | 2014 |
Protective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT(R141W) transgenic mice.
Topics: Animals; Cadherins; Cardiomyopathy, Dilated; Echocardiography; Heart; Humans; Hypertrophy; Ligusticum; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Muscle Proteins; Mutation; Myocardium; Platelet Aggregation Inhibitors; Pyrazines; Troponin T | 2010 |
[Effect of tetramethylpyrazine on JAK-STAT signal transduction in cardiomyocyte hypertrophy].
Topics: Angiotensin II; Animals; Cells, Cultured; Hypertrophy; Janus Kinases; Myocytes, Cardiac; Pyrazines; Rats; Rats, Wistar; Signal Transduction; STAT Transcription Factors | 2011 |
Loss of maximum attenuation and receptor reserve for isoprenaline at the beta 2-adrenoceptors of the portal veins of hypertensive rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Hypertension; Hypertrophy; Isoproterenol; Male; Nitroprusside; Portal Vein; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta; Vasodilator Agents; Verapamil | 1995 |
The chain of unexpected discovery: xanthopterin-stimulated renal mitosis.
Topics: Animals; Biochemistry; Creativity; History, 20th Century; Hyperplasia; Hypertrophy; Hypoxanthines; Kidney; Kidney Diseases; Mitosis; Pteridines; Purines; Pyrazines; Pyrimidines; Quinoxalines; Rats; Stimulation, Chemical; Structure-Activity Relationship; United Kingdom; Xanthine Oxidase; Xanthopterin | 1972 |